Target intelligence / Profile preview

Zinc finger DHHC-type palmitoyltransferase 9 (ZDHHC9)

Target
ZDHHC9
Molecular classification
Enzyme (specifically, protein-cysteine S-palmitoyltransferase), Zinc finger DHHC domain-containing protein family
01

Overview

Zinc finger DHHC-type palmitoyltransferase 9 (ZDHHC9) is an integral membrane enzyme of the DHHC (Asp-His-His-Cys) protein family that mediates the palmitoylation of protein substrates, including key signaling proteins such as HRAS, NRAS, ADRB2, CGAS, and GSDMD[1][2][3][4]. ZDHHC9 forms complexes with accessory proteins (e.g., golgin subfamily A member 7) and modulates processes including membrane association, protein localization, innate immunity, and cell death. Mutations in the ZDHHC9 gene are causative for X-linked intellectual disability syndromes, and altered expression or activity has implications for cancer progression and viral infection. The enzyme is a therapeutic target in research due to its regulatory roles in cell signaling and immune response[1][2][3][4].

Other names
Zinc finger DHHC-type palmitoyltransferase 9ZDHHC9DHHC9Palmitoyltransferase ZDHHC9Zinc finger protein 379Zinc finger protein 380CGI-89ZDHHC10CXorf11MMSA1MRXSRMRXSZantigen MMSA-1UNQ261/PRO298golgin subfamily A member 7 complex protein
02

Mechanism of action

Drugs/compounds targeting this molecule would typically act as palmitoyltransferase inhibitors or block the enzyme's function, thereby preventing palmitoylation of substrates like HRAS, NRAS, GSDMD, CGAS, and possibly viral proteins. Specific inhibition may disrupt signal transduction, innate immunity, or tumor cell growth depending on substrate.

03

Biological functions

Protein palmitoylation: Adds a palmitoyl group to cysteine residues on target proteins, a post-translational modification that regulates protein localization, stability, and functionRegulation of Ras signaling: Specifically palmitoylates and regulates HRAS and NRAS, which are key in signal transductionRegulation of G protein-coupled receptor (GPCR) signaling: May modulate GPCRs such as β2-adrenergic receptorRegulation of innate immunity: Palmitoylates CGAS to promote its dimerization and DNA sensing activityActivation of pyroptosis: Palmitoylates gasdermin-D (GSDMD), aiding its membrane translocation and pore formationStabilizes target proteins: e.g., CD38 in tumor cells, affecting protein stability
04

Disease associations

Intellectual disability: Mutations cause X-linked syndromic intellectual developmental disorders (Raymond type, Lujan-Fryns type)Cancer: Promotes glioma progression through plasma membrane localization of GLUT1Innate immunity/infection: Involved in palmitoylation of SARS-CoV-2 spike protein during infection, affecting viral assembly and fusionPotential roles in other diseases based on its substrates and pathway involvement
05

Safety considerations

Potential for developmental toxicity due to roles in neuronal signaling and cognitive functionPossible off-target effects owing to broad substrate rangeImmunological effects if innate immunity regulation is perturbed (e.g., via CGAS palmitoylation)
06

Interacting drugs

No approved drugs are currently indicated to directly target ZDHHC9; its role is under investigation as a target in cancer and viral infection settings
07

Biomarkers

Mutations in ZDHHC9 (e.g., R148W, P150S) for patient selection in intellectual disabilityLevels of palmitoylated Ras, CD38, or GSDMD may serve as efficacy biomarkers

Beyond the preview

Go deeper on Zinc finger DHHC-type palmitoyltransferase 9 (ZDHHC9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger DHHC-type palmitoyltransferase 9 (ZDHHC9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call